Your browser doesn't support javascript.
loading
Rituximab in the treatment of pembrolizumab-induced myasthenia gravis.
Crusz, S M; Radunovic, A; Shepherd, S; Shah, S; Newey, V; Phillips, M; Lim, L; Powles, T; Szlosarek, P W; Shamash, J; Rashid, S.
Afiliación
  • Crusz SM; Department of Medical Oncology, Barts Health NHS Trust, Basement Level, KGV Building, London, EC1A 7BE, UK. Electronic address: shanthini.crusz@bartshealth.nhs.uk.
  • Radunovic A; Department of Neurology, Barts Health NHS Trust, 4th Floor Front Block, Whitechapel, London, EH1 1BB, UK.
  • Shepherd S; Department Perioperative Medicine, Barts Health NHS Trust, 6th Floor, KGV Building, London, EC1A 7BE, UK.
  • Shah S; Department Perioperative Medicine, Barts Health NHS Trust, 6th Floor, KGV Building, London, EC1A 7BE, UK.
  • Newey V; Department Perioperative Medicine, Barts Health NHS Trust, 6th Floor, KGV Building, London, EC1A 7BE, UK.
  • Phillips M; Department of Medical Oncology, Barts Health NHS Trust, Basement Level, KGV Building, London, EC1A 7BE, UK.
  • Lim L; Department of Medical Oncology, Barts Health NHS Trust, Basement Level, KGV Building, London, EC1A 7BE, UK.
  • Powles T; Department of Medical Oncology, Barts Health NHS Trust, Basement Level, KGV Building, London, EC1A 7BE, UK.
  • Szlosarek PW; Department of Medical Oncology, Barts Health NHS Trust, Basement Level, KGV Building, London, EC1A 7BE, UK.
  • Shamash J; Department of Medical Oncology, Barts Health NHS Trust, Basement Level, KGV Building, London, EC1A 7BE, UK.
  • Rashid S; Department of Medical Oncology, Barts Health NHS Trust, Basement Level, KGV Building, London, EC1A 7BE, UK.
Eur J Cancer ; 102: 49-51, 2018 10.
Article en En | MEDLINE | ID: mdl-30138772
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Anticuerpos Monoclonales Humanizados / Rituximab / Antineoplásicos Inmunológicos / Factores Inmunológicos / Melanoma / Miastenia Gravis Tipo de estudio: Diagnostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Anticuerpos Monoclonales Humanizados / Rituximab / Antineoplásicos Inmunológicos / Factores Inmunológicos / Melanoma / Miastenia Gravis Tipo de estudio: Diagnostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article